Clinical Trials Logo

Colitis, Ulcerative clinical trials

View clinical trials related to Colitis, Ulcerative.

Filter by:

NCT ID: NCT00502294 Withdrawn - Clinical trials for Intravenous Steroid-Refractory Ulcerative Colitis

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis

Start date: n/a
Phase: Phase 3
Study type: Interventional

To compare the efficacy of visilizumab at 5 mcg/kg/day administered intravenously (IV) on Days 1 and 2 to placebo in subjects with IVSR-UC.

NCT ID: NCT00259571 Withdrawn - Ulcerative Colitis Clinical Trials

Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.

Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate if retarded phosphatidylcholine is as effective as mesalazin in preventing an acute episode in ulcerative colitis. The hypothesis is, that ulcerative colitis is cuased by a defect in the barrier function of the colonic mucus. The background of the study is the finding that the phosphatidylcholine content of the colonic mucus is reduced in patients with ulcerative colitis, in both healthy and inflamed parts of the colon.

NCT ID: NCT00213330 Withdrawn - Ulcerative Colitis Clinical Trials

Cerebral Resonance Magnetic Imaging During Rectal Distention

Start date: April 2003
Phase: N/A
Study type: Observational

Irritable bowel syndrome is responsible for chronic abdominal pain, diarrhea and/or constipation. It is a very frequent problem. However, the exact cause of irritable bowel syndrome remains unknown. The purpose of this study is to look for a different cerebral response by magnetic resonance imaging after rectal stimulation in patients with irritable bowel syndrome compared to healthy subjects and to patients with digestive organic disease. Our hypothesis is that irritable bowel syndrome could be a problem of cerebral integration of visceral stimulation.